Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

Despite the recent rash of tech stock sell-offs, the analysts at Wedbush believe this is a short-term phenomenon, and the ...

Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research ...

Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report)‘s stock had its “outperform” rating restated by analysts at Wedbush in a note issued to investors on Monday,RTT News reports. They presently have ...

Market fears over tariffs and growth have hit tech stocks, but Wedbush sees the dip as a buying opportunity for long-term investors ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on ...

Musk has become the face of the Trump administration’s slash-and-burn government downsizing efforts, known as the Department ...

Tesla stock is gaining ground on the heels of two significant news items today. President Trump made a statement of support for the company and its CEO, Elon Musk, and Wedbush put out analysis ...

It was almost an extraordinary scene in front of the White House. As Tesla shares have been tanking since the year began, President Donald Trump held remarks outside of the White House with the ...

Markets are still under a great deal of pressure. All thanks to more tariffs on Canada, Mexico, China and inflation threats, ...

Tesla (TSLA) stock has landed on Wedbush’s “best ideas list” as analyst Daniel Ives reaffirmed his bullish stance on the ...

The TSLA stock was up close to 5% on Tuesday. In the past one month, the stock has gone down around 30%. Wedbush Securities ...